Payer Needs in Emerging Markets: How Should These Needs be Included in Dermatology Drug Development Plans?

Catherine Copley-Merriman; Stephanie M. Barrows; Margaret M. Mordin; Susan L. Hogue; Kati Copley-Merriman; S Zelt; G Stone; Stephanie M. Barrows; Margaret M. Mordin; Susan L. Hogue

Payer Needs in Emerging Markets

How Should These Needs be Included in Dermatology Drug Development Plans?

Copley-Merriman, C., Zelt, S., Stone, G., Barrows, S., Mordin, M., & Hogue, S. (2014). Payer Needs in Emerging Markets: How Should These Needs be Included in Dermatology Drug Development Plans? Value in Health, 17(3), A290-A290.

Copy citation

Meet the Experts

View All Experts

Navigate to Kati Copley-Merriman

Kati Copley-Merriman

Recent Publications

Article

Treatment preferences among patients with mild-to-moderate atopic dermatitis

December 31, 2023

Article

Understanding how infection prevention influences nurses' task sequencing using a mixed-methods, simulation-based approach

December 01, 2023

Article

Consensus-based framework for evaluating data modernization initiatives

October 01, 2023

Article

∆8-THC-COOH cross-reactivity with cannabinoid immunoassay kits and interference in chromatographic testing methods

September 15, 2023

View All Publications